ZMIZ1 and triple-negative breast carcinoma: Analysis of two ER-positive (MCF7 and T47D) and one triple negative breast cancer (TNBC) model (MDA-MB-231) showed that knockdown of ZMIZ1 reduced cell proliferation in all three cell lines (Fig. 4) (ANOVA, P< 0.001).